Myoclonic Epilepsies, Progressive
Showing 1 - 25 of 4,475
Myoclonus Epilepsies, Progressive Trial in Philadelphia (AUT00201, Placebo)
Recruiting
- Myoclonus Epilepsies, Progressive
- AUT00201
- Placebo
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, Penn Epilepsy Center
May 15, 2023
Epilepsies, Myoclonic, Drug Resistant Epilepsy Trial (Lorcaserin)
Available
- Epilepsies, Myoclonic
- Drug Resistant Epilepsy
- (no location specified)
Jun 1, 2022
Childhood Absence Epilepsy, Juvenile Absence Epilepsy, Juvenile Myoclonic Epilepsy Trial in Vancouver (Flunarizine
Terminated
- Childhood Absence Epilepsy
- +2 more
- Flunarizine Hydrochloride
-
Vancouver, British Columbia, CanadaBC Children's Hospital
Nov 29, 2023
Dravet Syndrome Trial (Fenfluramine Hydrochloride)
Approved for marketing
- Dravet Syndrome
- Fenfluramine Hydrochloride
- (no location specified)
Nov 8, 2022
Gather Information About Overall Occurrence and New Cases of
Not yet recruiting
- Dravet Syndrome (DS)
- Lennox-Gastaut Syndrome (LGS)
- No intervention
-
Valencia, SpainHospital Universitari i Politècnic La Fe
Jul 31, 2023
GABA Biomarkers in Dravet Syndrome
Recruiting
- Dravet Syndrome
- GABA Blood Level
-
Fort Worth, TexasCook Children's Medical Center
Dec 13, 2022
Dravet Syndrome, Lennox Gastaut Syndrome, Developmental and Epileptic Encephalopathies Trial run by the Longboard
Available
- Dravet Syndrome
- +2 more
-
Bethesda, MarylandMid-Atlantic Epilepsy and Sleep Center
Nov 19, 2023
Treatment of Gait Disorders in Children With Dravet Syndrome
Completed
- Dravet Syndrome
- Severe Myoclonic Epilepsy of Infancy
- Clinical gait analysis
-
Antwerp, Belgium
- +2 more
Apr 7, 2022
Dravet Syndrome, Dravet Syndrome, Intractable Trial in Toronto (Fenfluramine)
Not yet recruiting
- Dravet Syndrome
- Dravet Syndrome, Intractable
-
Toronto, Ontario, CanadaToronto Western Hospital
Nov 8, 2022
Dravet Syndrome Trial in Melbourne (ETX101)
Not yet recruiting
- Dravet Syndrome
-
Melbourne, AustraliaThe Royal Children's Hospital
Oct 30, 2023
Study of Rare Epileptic Syndromes in Children and Adolescents
Not yet recruiting
- Epilepsy
- +2 more
-
Paris, FranceHopital Robert Debré - Neurologie
Nov 8, 2021
Dravet Syndrome, Epilepsy Trial in Edegem, Bron, Bonn (Video-electroencephalography, Blood Samples)
Not yet recruiting
- Dravet Syndrome
- Epilepsy
- Video-electroencephalography
- Blood Samples
-
Edegem, Belgium
- +2 more
Jul 22, 2022
Lennox-Gastaut Syndrome, Dravet Syndrome Trial in Saint Paul (12-Lead ECG, Cannabidiol)
Terminated
- Lennox-Gastaut Syndrome
- Dravet Syndrome
- 12-Lead ECG
- Cannabidiol
-
Saint Paul, MinnesotaGillette Children's Specialty Healthcare
Aug 2, 2022
Epidyolex® in Lennox Gastaut and Dravet Syndrome:Observational
Not yet recruiting
- Lennox Gastaut Syndrome
- Dravet Syndrome
- Epidiolex 100 mg/mL Oral Solution
-
Roma, ItalyOspedale Pediatrico Bambino Gesù (OPBG)
Aug 1, 2022
Transcranial Magnetic Stimulation to Measure Cortical
Recruiting
- Dravet Syndrome
- Transcranial Magnetic Stimulation (TMS)
- Electroencephalogram (EEG)
-
Boston, MassachusettsBoston Children's Hospital
Mar 8, 2022
Neuronal Excitability of HCN1 Channel Mutations in Dravet
Recruiting
- Dravet Syndrome
- measure of neuronal excitability
-
Paris, FranceFondation Ophtalmologique Adolphe de Rothschild
Dec 23, 2021
Cannabidiol (CBD) and Its Effects in Severe Epilepsy
Withdrawn
- Dravet Syndrome
- Lennox Gastaut Syndrome
- (no location specified)
Dec 2, 2021
Dravet Syndrome, Lennox Gastaut Syndrome Trial in Atlanta, Tacoma (ZX008 0.2 to 0.8 mg/kg/day, Cannabidiol)
Completed
- Dravet Syndrome
- Lennox Gastaut Syndrome
- ZX008 0.2 to 0.8 mg/kg/day
- Cannabidiol
-
Atlanta, Georgia
- +1 more
Oct 31, 2022
Epilepsy Trial in New York (ataluren, Placebo)
Completed
- Epilepsy
- ataluren
- Placebo
-
New York, New YorkNew York University School of Medicine
Sep 7, 2021
A Single-Site Tissue Repository Providing Annotated Biospecimens
Recruiting
- Age-Related Macular Degeneration
- +46 more
- Specimen sample
-
Waltham, MassachusettsSanguine Biosciences
Nov 22, 2022